Pediatric Alopecia Areata Correlates With Autoimmune and Metabolic Disorders
The prevalence of comorbidities in pediatric patients with alopecia areata was determined, using a large de-identified aggregated patient database.
Systemic Lupus Erythematosus
Flare Frequency Associated With Reduced Quality of Life and Family Role Functioning in SLE
Lupus flares contributed to impaired functional and psychologic well-being, family functioning, and number of monthly healthy days.
Low Frequency of Flares During and After Pregnancy in Patients With Inactive or Stable Lupus
Researchers identified predictors of flares during and after pregnancy in patients with inactive or stable disease activity and characterized and estimated the frequency of postpartum flares.
National Rosacea Society Publishes Updated Guideline on Standard Rosacea Management
An update to rosacea treatment guidelines provides a comprehensive summary of management options, including expert evaluations–based on the phenotypes of each patient–to serve as a guide for tailoring treatment and care.
Chronic Damage Not Affected by Pregnancy in Systemic Lupus Erythematosus
Researchers evaluated the chronic damage associated with pregnancies before and after the diagnosis of systemic lupus erythematosus.
In-Hospital Maternal Mortality Down in Pregnancies With Lupus
Mortality decrease greater in systemic lupus erythematosus pregnancies than in non-SLE pregnancies.
Managing Pediatric Systemic Lupus Erythematosus in Thrombotic Thrombocytopenic Purpura
Researchers recommended performing lactate dehydrogenase level and blood smear testing in patients with renal and neurological symptoms.
Lupus Affects Emotional, Mental Well-Being of Patients
Most patients report not having participated in a lupus clinical trial, despite interest.
First Treatment for Children With Systemic Lupus Erythematosus Gets FDA Approval
The Food and Drug Administration (FDA) has approved the intravenous (IV) formulation of Benlysta (belimumab; GlaxoSmithKline) for the treatment of pediatric patients ≥5 years old with active, autoantibody-positive, systemic lupus erythematosus (SLE) who are receiving standard therapy.
Managing Systemic Lupus Erythematosus: Updated 2019 EULAR Recommendations Released
EULAR has released updated 2019 recommendations for the management of systemic lupus erythematosus.
-
Loading...
-
Loading...
Next post in Rheumatology Information Center
